Nanoknife is a brand new tumor ablation therapy, which has been approved by US FDA into clinical use and has passed EU CE accreditation. Ministry of Public Health of China approved the technology for cancer treatment in June, 2015. So far, Nanonife has been introduced by over 100 hospitals all over the world, and it has successfully treated more than 10,000 cancer patients. Nanoknife for pancreatic cancer, liver cancer, etc., were performed successfully in St. Stamford Modern Cancer Hospital Guangzhou and has gained good therapeutic effect.
International authoritative oncologist Pro. Ke Liqun will be invited to introduce the new international anticancer technology—Nanoknife. If you want to have on-site consultation, please take your medical reports, such as PET/CT, SCAN/MRI, etc., Professor Ke Liqun will give you comprehensive treatment suggestions.
During his 30 years medical experiences, Professor Ke Liqun has treated thousands of cancer patients and gained rich experiences in cancer treatment. He clearly knows the feeling and suffering of cancer patients. Therefore, he combined his medical theories with his excellent medical skills, and then focused on research, practice and innovation. And, he summarizes a cancer treatment principle named “Four Combinations”. His innovations in cancer treatments not only help treat cancer effectively and lower the risk of recurrence and metastasis, but also make positive contributions and exposure to the innovation and development of cancer treatment. Moreover, Prof. Ke has published many authoritative books, such as Answering Cancer Patients’ Questions, Modern Cancer Therapeutics.